ArticlePloS one2017
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.
Jochen Dutzmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it